Back to search

Article

Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice

2022-07-22

Abstract excerpt

<h4>Background: </h4> Rifaximin has been increasingly applied in irritable bowel syndrome (IBS) treatment. Whether there were differences in the effects of rifaximin on microbiota from different intestinal segments, especially the small intestine where rifaximin predominantly acted, has not been confirmed. Methods In this study, we used Trichinella spiralis infection to induce post infectious irritable bowel synd...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
087d75fe-cdf5-5ad8-b5ff-81c2817c5b0b
DOI
10.21203/rs.3.rs-1794729/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS miceDOI 10.21203/rs.3.rs-1794729/v1
Select a neighboring publication to make it the new centre.